Margot Laly

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 163 citations · Full text

Solid Cancer Patients, Cancer Epidemiology, Disease Risk Assessment +12

LBA77 5-fluorouracil and oxaliplatin with or without docetaxel in the first-line treatment of HER2 negative locally advanced (LA) unresectable or metastatic gastric or gastro-esophageal junction (GEJ) adenocarcinoma (GASTFOX-PRODIGE 51): A randomized phase III trial sponsored by the FFCD

Aziz Zaanan, Olivier Bouché, Christelle de la Fouchardière et al. · Annals of Oncology · 2023 · 28 citations · Full text

Lba77 5-Fluorouracil, Esophageal Cancer, Gastrointestinal Oncology +8

TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trial

Aziz Zaanan, Olivier Bouché, Christelle de la Fouchardière et al. · The Lancet Oncology · 2025 · 13 citations

Contribution of the OC Sensor® immunoassay in comparison to the Hemoccult II® guaiac-test in organized colorectal cancer screening

Carole Vitellius, Margot Laly, Anne-Sophie Banaszuk et al. · European Journal of Epidemiology · 2018 · 12 citations

Cancer Detection, Cancer Screening, Medicine +11